All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Educational theme│ The genomic landscape, biology, epidemiology, and prognosis of Ph-like ALL
As the genomic understanding of Ph-like ALL continues to develop, there is an opportunity to consider targeted therapeutic approaches that aim to reduce...
Blinatumomab injection approved in China for pediatric relapsed or refractory CD19+ B-cell precursor acute lymphoblastic leukemia
On May 4, 2022, it was announced that blinatumomab for injection received conditional approval from the China National...
"In partnership with the European School of Haematology, the ALL Hub will contribute to the dissemination of knowledge and favor fruitful translational discussions in the field of ALL."
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.